跳至主要内容
临床试验/NCT04280874
NCT04280874已完成4 期

Comparison of Intracervical and Intravaginal Application of Prostaglandin E2 for Induction of Labour in Term Pregnancies With Unfavourable Cervix

Clinical Hospital Merkur1 个研究点 分布在 1 个国家目标入组 212 人开始时间: 2018年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
212
试验地点
1
主要终点
time period between beginning of labor induction to delivery

研究概览

简要总结

This is a prospective randomized trial comparing two prostaglandin E2 (dinoprostone) agents used for labor induction in pregnant women with term pregnancies and unfavorable cervix.

详细描述

This prospective randomized trial includes pregnant women with term pregnancies, indication for labor induction and an unfavorable cervix. These women are randomized into two groups: one group is induced using an intracervical prostaglandin E2 (PGE2, dinoprostone) formulation, the other using an intravaginal PGE2 formulation. Main outcome is time period between beginning of labor induction to delivery, and a reduction of four hours is considered clinically significant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

two dinoprostone agents are randomly applied and compared - one in patient's cervix and the other in vagina without the patient knowing which agent is applied

入排标准

性别
Female
接受健康志愿者

入选标准

  • term pregnancies (> 37 weeks gestation)
  • unfavourable cervix (Bishop score <6)
  • indication for labor induction
  • absence of uterine contractions
  • reassuring cardiotocography

排除标准

  • ruptured membranes
  • scar uterus (previous caesarean section or uterus surgery)
  • pregnancy complications: intrauterine growth restriction; oligohydramnios, pre-eclampsia, non-reassuring/pathological cardiotocography, cholestasis in pregnancy, diabetes mellitus, multifetal pregnancy, breech presentation

研究组 & 干预措施

GROUP A

Active Comparator

106 randomly selected pregnant women

干预措施: Dinoprostone 0.5 MG (Drug)

GROUP B

Active Comparator

106 randomly selected pregnant women

干预措施: Dinoprostone 2 MG/2.5 ML Vaginal Gel/Jelly (Drug)

结局指标

主要结局

time period between beginning of labor induction to delivery

时间窗: 5 days

hours (difference of 4 hours or more is considered significant)

次要结局

  • number of deliveries by caesarean section or instrumental deliveries(7 days)
  • number of births within 24h of start of labor induction(7 days)
  • number of uterus hyperstimulation(7 days)

研究者

发起方
Clinical Hospital Merkur
申办方类型
Other
责任方
Principal Investigator
主要研究者

Katja Vince

Principal Investigator

Clinical Hospital Merkur

研究点 (1)

Loading locations...

相似试验